Nicotine-mediated effects in neuronal and mouse models of synucleinopathy

IntroductionAlpha-synuclein (α-Syn) aggregation, transmission, and contribution to neurotoxicity represent central mechanisms underlying Parkinson’s disease. The plant alkaloid “nicotine” was reported to attenuate α-Syn aggregation in different models, but its precise mode of action remains unclear....

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed Bilal Fares, Omar Alijevic, Stephanie Johne, Cassia Overk, Makoto Hashimoto, Athanasios Kondylis, Anthony Adame, Remi Dulize, Dariusz Peric, Catherine Nury, James Battey, Emmanuel Guedj, Nicolas Sierro, Damian Mc Hugh, Edward Rockenstein, Changyoun Kim, Robert A. Rissman, Julia Hoeng, Manuel C. Peitsch, Eliezer Masliah, Carole Mathis
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2023.1239009/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849413032029978624
author Mohamed Bilal Fares
Omar Alijevic
Stephanie Johne
Cassia Overk
Makoto Hashimoto
Athanasios Kondylis
Anthony Adame
Remi Dulize
Dariusz Peric
Catherine Nury
James Battey
Emmanuel Guedj
Nicolas Sierro
Damian Mc Hugh
Edward Rockenstein
Changyoun Kim
Robert A. Rissman
Julia Hoeng
Manuel C. Peitsch
Eliezer Masliah
Carole Mathis
author_facet Mohamed Bilal Fares
Omar Alijevic
Stephanie Johne
Cassia Overk
Makoto Hashimoto
Athanasios Kondylis
Anthony Adame
Remi Dulize
Dariusz Peric
Catherine Nury
James Battey
Emmanuel Guedj
Nicolas Sierro
Damian Mc Hugh
Edward Rockenstein
Changyoun Kim
Robert A. Rissman
Julia Hoeng
Manuel C. Peitsch
Eliezer Masliah
Carole Mathis
author_sort Mohamed Bilal Fares
collection DOAJ
description IntroductionAlpha-synuclein (α-Syn) aggregation, transmission, and contribution to neurotoxicity represent central mechanisms underlying Parkinson’s disease. The plant alkaloid “nicotine” was reported to attenuate α-Syn aggregation in different models, but its precise mode of action remains unclear.MethodsIn this study, we investigated the effect of 2-week chronic nicotine treatment on α-Syn aggregation, neuroinflammation, neurodegeneration, and motor deficits in D-line α-Syn transgenic mice. We also established a novel humanized neuronal model of α-Syn aggregation and toxicity based on treatment of dopaminergic neurons derived from human induced pluripotent stem cells (iPSC) with α-Syn preformed fibrils (PFF) and applied this model to investigate the effects of nicotine and other compounds and their modes of action.Results and discussionOverall, our results showed that nicotine attenuated α-Syn-provoked neuropathology in both models. Moreover, when investigating the role of nicotinic acetylcholine receptor (nAChR) signaling in nicotine’s neuroprotective effects in iPSC-derived dopaminergic neurons, we observed that while α4-specific antagonists reduced the nicotine-induced calcium response, α4 agonists (e.g., AZD1446 and anatabine) mediated similar neuroprotective responses against α-Syn PFF-provoked neurodegeneration. Our results show that nicotine attenuates α-Syn-provoked neuropathology in vivo and in a humanized neuronal model of synucleinopathy and that activation of α4β2 nicotinic receptors might mediate these neuroprotective effects.
format Article
id doaj-art-eae8ebe4bbe94ac488d6544ea8c9efeb
institution Kabale University
issn 1662-453X
language English
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj-art-eae8ebe4bbe94ac488d6544ea8c9efeb2025-08-20T03:34:14ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2023-08-011710.3389/fnins.2023.12390091239009Nicotine-mediated effects in neuronal and mouse models of synucleinopathyMohamed Bilal Fares0Omar Alijevic1Stephanie Johne2Cassia Overk3Makoto Hashimoto4Athanasios Kondylis5Anthony Adame6Remi Dulize7Dariusz Peric8Catherine Nury9James Battey10Emmanuel Guedj11Nicolas Sierro12Damian Mc Hugh13Edward Rockenstein14Changyoun Kim15Robert A. Rissman16Julia Hoeng17Manuel C. Peitsch18Eliezer Masliah19Carole Mathis20PMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandDepartment of Neurosciences, University of California, San Diego, San Diego, CA, United StatesDepartment of Neurosciences, University of California, San Diego, San Diego, CA, United StatesPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandDepartment of Neurosciences, University of California, San Diego, San Diego, CA, United StatesPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandDepartment of Neurosciences, University of California, San Diego, San Diego, CA, United StatesDepartment of Neurosciences, University of California, San Diego, San Diego, CA, United StatesDepartment of Neurosciences, University of California, San Diego, San Diego, CA, United StatesPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandDepartment of Neurosciences, University of California, San Diego, San Diego, CA, United StatesPMI R&D, Philip Morris Products S.A., Neuchâtel, SwitzerlandIntroductionAlpha-synuclein (α-Syn) aggregation, transmission, and contribution to neurotoxicity represent central mechanisms underlying Parkinson’s disease. The plant alkaloid “nicotine” was reported to attenuate α-Syn aggregation in different models, but its precise mode of action remains unclear.MethodsIn this study, we investigated the effect of 2-week chronic nicotine treatment on α-Syn aggregation, neuroinflammation, neurodegeneration, and motor deficits in D-line α-Syn transgenic mice. We also established a novel humanized neuronal model of α-Syn aggregation and toxicity based on treatment of dopaminergic neurons derived from human induced pluripotent stem cells (iPSC) with α-Syn preformed fibrils (PFF) and applied this model to investigate the effects of nicotine and other compounds and their modes of action.Results and discussionOverall, our results showed that nicotine attenuated α-Syn-provoked neuropathology in both models. Moreover, when investigating the role of nicotinic acetylcholine receptor (nAChR) signaling in nicotine’s neuroprotective effects in iPSC-derived dopaminergic neurons, we observed that while α4-specific antagonists reduced the nicotine-induced calcium response, α4 agonists (e.g., AZD1446 and anatabine) mediated similar neuroprotective responses against α-Syn PFF-provoked neurodegeneration. Our results show that nicotine attenuates α-Syn-provoked neuropathology in vivo and in a humanized neuronal model of synucleinopathy and that activation of α4β2 nicotinic receptors might mediate these neuroprotective effects.https://www.frontiersin.org/articles/10.3389/fnins.2023.1239009/fullsynucleinopathyinduced pluripotent stem cell (iPSC)transgenic micenicotinenicotinic acetylcholine receptors (nAChR)neuroprotection
spellingShingle Mohamed Bilal Fares
Omar Alijevic
Stephanie Johne
Cassia Overk
Makoto Hashimoto
Athanasios Kondylis
Anthony Adame
Remi Dulize
Dariusz Peric
Catherine Nury
James Battey
Emmanuel Guedj
Nicolas Sierro
Damian Mc Hugh
Edward Rockenstein
Changyoun Kim
Robert A. Rissman
Julia Hoeng
Manuel C. Peitsch
Eliezer Masliah
Carole Mathis
Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
Frontiers in Neuroscience
synucleinopathy
induced pluripotent stem cell (iPSC)
transgenic mice
nicotine
nicotinic acetylcholine receptors (nAChR)
neuroprotection
title Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
title_full Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
title_fullStr Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
title_full_unstemmed Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
title_short Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
title_sort nicotine mediated effects in neuronal and mouse models of synucleinopathy
topic synucleinopathy
induced pluripotent stem cell (iPSC)
transgenic mice
nicotine
nicotinic acetylcholine receptors (nAChR)
neuroprotection
url https://www.frontiersin.org/articles/10.3389/fnins.2023.1239009/full
work_keys_str_mv AT mohamedbilalfares nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT omaralijevic nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT stephaniejohne nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT cassiaoverk nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT makotohashimoto nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT athanasioskondylis nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT anthonyadame nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT remidulize nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT dariuszperic nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT catherinenury nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT jamesbattey nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT emmanuelguedj nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT nicolassierro nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT damianmchugh nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT edwardrockenstein nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT changyounkim nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT robertarissman nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT juliahoeng nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT manuelcpeitsch nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT eliezermasliah nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy
AT carolemathis nicotinemediatedeffectsinneuronalandmousemodelsofsynucleinopathy